An Asian patient with intraocular lymphoma treated by intravitreal methotrexate

被引：21
|
作者：
Wang, Jia-Kang
Yang, Chung-May
Lin, Chang-Ping
Shan, Yin-Dong
Lo, Andy Y.
Tien, Hwei-Fang
机构：
[1] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 100, Taiwan
[2] Far Eastern Mem Hosp, Dept Ophthalmol, Taipei, Taiwan
[3] Natl Taiwan Univ, Dept Internal Med, Taipei 10764, Taiwan
来源：
JAPANESE JOURNAL OF OPHTHALMOLOGY | 2006年 / 50卷 / 05期
关键词：
chemotherapy; intraocular lymphoma; intravitreal injection; methotrexate; primary central nervous system lymphoma;
D O I：
10.1007/s10384-005-0327-4
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Background: To demonstrate the efficacy of intravitreal methotrexate for treating intraocular lymphoma. Case: A 55-year-old immunocompetent Asian man was diagnosed with intraocular lymphoma. Observations: The patient was initially managed by intravenous administration of high-dose methotrexate. Because vitreous cells persisted after systemic chemotherapy, methotrexate was given intravitreally thereafter. There was only self-limited corneal epitheliopathy without major complications following intraocular injections. Ocular remission was sustained during a 21-month follow-up. Conclusion: Intravitreal methotrexate is an effective, repeatable, and safe treatment for intraocular lymphoma.
引用
收藏
页码：474 / 478
页数：5
相关论文
共 50 条
  • [31] Primary intraocular lymphoma arising during methotrexate treatment of temporal arteritis
    Rizkalla, K
    Rodrigues, S
    Proulx, A
    Tingey, DP
    Heathcote, JG
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2005, 40 (05): : 585 - 592
  • [32] Case Report: Intraocular Hemorrhage in a Primary Vitreoretinal Lymphoma Patient Treated With Zanubrutinib
    Zhang, Xiao
    Dai, Rongping
    Zhao, Chan
    Zhang, Meifen
    FRONTIERS IN MEDICINE, 2022, 9
  • [33] Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate
    Tingting Jiang
    Junxiang Gu
    Shixue Liu
    Qing Chang
    BMC Ophthalmology, 22
  • [34] Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate
    Jiang, Tingting
    Gu, Junxiang
    Liu, Shixue
    Chang, Qing
    BMC OPHTHALMOLOGY, 2022, 22 (01)
  • [35] Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate
    Huiying Zhao
    Xiaona Wang
    Yu Mao
    Xiaoyan Peng
    BMC Ophthalmology, 20
  • [36] Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate
    Zhao, Huiying
    Wang, Xiaona
    Mao, Yu
    Peng, Xiaoyan
    BMC OPHTHALMOLOGY, 2020, 20 (01)
  • [37] Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients
    Xian Zhou
    Xianjin Zhou
    Huimin Shi
    Jie Lai
    Qingping Wang
    Yi Li
    Kun Chen
    Qingjian Li
    Qiang Zhou
    Xia Cao
    Bobin Chen
    Jianjiang Xiao
    BMC Ophthalmology, 20
  • [38] Methotrexate-Associated Lymphoproliferative Disorder with Intraocular Involvement Improved with Intravitreal Methotrexate and Chemotherapy: A Case Report
    Yamasaki, Atsushi
    Hoshi, Futoshi
    Yamada, Fusae
    Tamaru, Jun-Ichi
    Tokuhira, Michihide
    Obata, Hiroto
    CASE REPORTS IN OPHTHALMOLOGY, 2024, 15 (01): : 807 - 814
  • [39] Combined intravitreal methotrexate and immunochemotherapy followed by reduced-dose whole-brain radiotherapy for newly diagnosed B-cell primary intraocular lymphoma
    Kaburaki, Toshikatu
    Taoka, Kazuki
    Matsuda, Junko
    Yamashita, Hideomi
    Matsuda, Izuru
    Tsuji, Hideki
    Tanaka, Rie
    Nakazaki, Kumi
    Nakamura, Fumihiko
    Kamiya, Kohei
    Kurokawa, Mineo
    Ohtomo, Kuni
    Aihara, Makoto
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (02) : 246 - 255
  • [40] Intraocular lymphoma: a clinical perspective
    Davis, J. L.
    EYE, 2013, 27 (02) : 153 - 162
12345